PRAX Praxis Precision Medicines Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: PRAX

Price (delayed)

$282.12

Market cap

$7.88B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$12.94

Enterprise value

$7.4B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 5
Highlights
The quick ratio has soared by 149% year-on-year
The debt has increased by 44% year-on-year but it has declined by 24% since the previous quarter
PRAX's EPS is down by 4.8% year-on-year but it is up by 3.3% since the previous quarter
The gross profit has dropped by 100% year-on-year
The revenue has dropped by 100% year-on-year
Sector: Healthcare
Industry: Biotechnology
Website: http://www.praxismedicines.com
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of PRAX

PRAX stock price

How has the Praxis Precision Medicines stock price performed over time
Intraday
-6.16%
1 week
-8.7%
1 month
-24.96%
1 year
480.49%
YTD
-4.28%
QTD
-15.73%

Financial performance

How have Praxis Precision Medicines's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$378.17M
Net income
-$339.13M
Gross margin
N/A
Net margin
N/A
The gross profit has dropped by 100% year-on-year
The revenue has dropped by 100% year-on-year
The operating income has declined by 39% year-on-year and by 6% since the previous quarter
The net income has contracted by 35% YoY and by 3.9% from the previous quarter

Price vs fundamentals

How does PRAX's price correlate with its fundamentals

Growth

What is Praxis Precision Medicines's growth rate over time

Valuation

What is Praxis Precision Medicines stock price valuation
P/E
N/A
P/B
5.86
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
PRAX's EPS is down by 4.8% year-on-year but it is up by 3.3% since the previous quarter
PRAX's P/B is 116% above its 5-year quarterly average of 2.9
PRAX's equity is down by 4.9% from the previous quarter
The revenue has dropped by 100% year-on-year

Efficiency

How efficient is Praxis Precision Medicines business performance
The company's return on invested capital rose by 47% YoY and by 22% QoQ
Praxis Precision Medicines's ROE has increased by 43% YoY and by 21% from the previous quarter
Praxis Precision Medicines's ROA has increased by 41% YoY and by 19% from the previous quarter

Dividends

What is PRAX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PRAX.

Financial health

How did Praxis Precision Medicines financials performed over time
The quick ratio has soared by 149% year-on-year
PRAX's current ratio has surged by 149% year-on-year
The debt is 100% smaller than the equity
The debt has increased by 44% year-on-year but it has declined by 24% since the previous quarter
PRAX's equity is down by 4.9% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.